REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Wuhan Hiteck Biological Pharma Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Wuhan Hiteck Biological Pharma Co.,Ltd Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Wuhan Hiteck Biological Pharma Co., Ltd. develops, produces and sells biological products, thrombin and other chemicals. It was founded in 1992 and is headquartered in Wuhan City, China.

Headquarters
Haite Science and Technology Park, Economic and Technological Development Zone, Wuhan City, Hubei Province
Wuhan; Hubei; Postal Code: 430056

Contact Details: Purchase the Wuhan Hiteck Biological Pharma Co.,Ltd report to view the information.

Website: http://www.hiteck.com.cn

Basic Information
Total Employees:
Purchase the Wuhan Hiteck Biological Pharma Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Wuhan Hiteck Biological Pharma Co.,Ltd report to view the information.
Registered Capital:
Purchase the Wuhan Hiteck Biological Pharma Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Wuhan Hiteck Biological Pharma Co.,Ltd report to view the information.
Incorporation Date:
April 08, 1992
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
19.26%
Purchase this report to view the information.
11.3%
Purchase this report to view the information.
8.44%
Purchase this report to view the information.
2.32%
Purchase this report to view the information.
2.29%
Subsidiaries
Hainan Hanhe Pharmaceutical Co., Ltd
100%
Haite Biological (Xiamen) Co., Ltd.
100%
Hanrui Pharmaceutical (Jingmen) Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Wuhan Hiteck Biological Pharma Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
2.87%▲
Total operating revenue
2.22%▲
Operating profit (EBIT)
-14.47%▼
Net Profit (Loss) for the Period
-42.48%▼
Total assets
0.57%▲
Total equity
-5.42%▼
Operating Profit Margin (ROS)
-1.11%▼
Net Profit Margin
-2.6%▼
Return on Equity (ROE)
-0.58%▼
Debt to Equity Ratio
-0.58%▼
Quick Ratio
-1.99%▼
Cash Ratio
-0.38%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo